AG˹ٷ

STOCK TITAN

FOXO TECHNOLOGIES INC. ANNOUNCES LICENSE RENEWAL AND PROVIDES OPERATIONAL UPDATE FOR MYRTLE RECOVERY CENTERS, INC.

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

FOXO Technologies (NYSE American: FOXO) announced that its behavioral health subsidiary, Myrtle Recovery Centers, has successfully renewed its operating license for its Oneida, Tennessee facility for another year. The renewal was granted by Tennessee's Department of Mental Health and Substance Abuse Services following a successful annual inspection.

The facility, which provides alcohol and drug residential treatment services, is currently operating at full capacity with a waiting list for future admissions. Management is actively exploring strategic expansion options, including opening a second location and potential acquisitions in the behavioral health sector.

FOXO Technologies (NYSE American: FOXO) ha annunciato che la sua controllata nel settore della salute comportamentale, Myrtle Recovery Centers, ha rinnovato con successo la licenza operativa per la sua struttura di Oneida, Tennessee, per un altro anno. Il rinnovo è stato concesso dal Dipartimento della Salute Mentale e dei Servizi per l’Abuso di Sostanze del Tennessee, a seguito di un'ispezione annuale positiva.

La struttura, che offre servizi residenziali di trattamento per alcol e droghe, sta attualmente operando a piena capacità con una lista d’attesa per future ammissioni. La direzione sta esplorando attivamente opzioni strategiche di espansione, tra cui l’apertura di una seconda sede e potenziali acquisizioni nel settore della salute comportamentale.

FOXO Technologies (NYSE American: FOXO) anunció que su subsidiaria de salud conductual, Myrtle Recovery Centers, ha renovado con éxito su licencia operativa para su instalación en Oneida, Tennessee, por un año más. La renovación fue otorgada por el Departamento de Salud Mental y Servicios para el Abuso de Sustancias de Tennessee tras una inspección anual satisfactoria.

La instalación, que ofrece servicios residenciales de tratamiento para alcohol y drogas, actualmente opera a plena capacidad con una lista de espera para futuras admisiones. La dirección está explorando activamente opciones estratégicas de expansión, incluyendo la apertura de una segunda ubicación y posibles adquisiciones en el sector de salud conductual.

FOXO Technologies (NYSE American: FOXO)� 자회사인 행동 건강 센터� Myrtle Recovery Centers가 테네시주 오니� 시설� 운영 허가� 1� � 성공적으� 갱신했다� 발표했습니다. 이번 갱신은 테네� 정신 건강 � 약물 남용 서비� 부서의 연례 점검� 통과� � 승인되었습니�.

� 시설은 알코� � 약물 주거 치료 서비스를 제공하며, 현재 전면 가� 중이� 대기자 명단� 있습니다. 경영진은 � 번째 지� 개설� 행동 건강 분야에서� 인수 가능성� 포함� 전략� 확장 방안� 적극적으� 모색하고 있습니다.

FOXO Technologies (NYSE American : FOXO) a annoncé que sa filiale spécialisée en santé comportementale, Myrtle Recovery Centers, a renouvelé avec succès sa licence d’exploitation pour son établissement de Oneida, Tennessee, pour une année supplémentaire. Le renouvellement a été accordé par le Département de la Santé Mentale et des Services de Lutte contre la Toxicomanie du Tennessee suite à une inspection annuelle réussie.

L’établissement, qui propose des services résidentiels de traitement de l’alcoolisme et de la toxicomanie, fonctionne actuellement à pleine capacité avec une liste d’attente pour les admissions futures. La direction explore activement des options stratégiques d’expansion, notamment l’ouverture d’un second site et d’éventuelles acquisitions dans le secteur de la santé comportementale.

FOXO Technologies (NYSE American: FOXO) gab bekannt, dass seine Tochtergesellschaft im Bereich Verhaltensgesundheit, Myrtle Recovery Centers, die Betriebslizenz für seine Einrichtung in Oneida, Tennessee, erfolgreich um ein weiteres Jahr erneuert hat. Die Erneuerung wurde vom Tennessee Department of Mental Health and Substance Abuse Services nach einer erfolgreichen Jahresinspektion erteilt.

Die Einrichtung, die stationäre Behandlungsdienste für Alkohol- und Drogenabhängigkeit anbietet, arbeitet derzeit mit voller Kapazität und einer Warteliste für zukünftige Aufnahmen. Das Management prüft aktiv strategische Erweiterungsoptionen, einschließlich der Eröffnung eines zweiten Standorts und möglicher Übernahmen im Bereich der Verhaltensgesundheit.

Positive
  • Facility operating at full capacity with waiting list indicating strong demand
  • Successfully renewed operating license after passing annual inspection
  • Active expansion plans including potential second location and acquisitions
Negative
  • Limited current capacity constraining growth potential

WEST PALM BEACH, FLORIDA, July 31, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies, Inc., (NYSE American: FOXO)(“FOXO� or the �Company�) today announced that its behavioral health subsidiary, Myrtle Recovery Centers, Inc., has renewed its operating license for its Oneida, TN location for another year. The license renewal to operate an alcohol and drug residential treatment facility was granted by the State of Tennessee’s Department of Mental Health and Substance Abuse Services after a successful annual inspection.

Robert Merritt, CEO of Myrtle Recovery Centers, Inc. noted, “We are pleased that the state renewed our operating license for another year. Currently, the facility is at full capacity, and we are managing a waiting list for future admissions.� “We are leveraging the success of Myrtle’s first operating location through active consideration of various strategic options for expansion,� stated Seamus Lagan, Chief Executive Officer of parent company, FOXO Technologies Inc. “We believe we will soon be in a position to initiate opening a second location and continue to consider possible acquisitions in the sector�.

dzܳFOXO Technologies Inc. (“FOXO�)

FOXO owns and operates three subsidiaries.

Rennova Community Health, Inc., owns and operates Scott County Community Hospital, Inc. (d/b/a Big South Fork Medical Center), a critical access designated (CAH) hospital in East Tennessee.

Myrtle Recovery Centers, Inc., a 30-bed behavioral health facility in East Tennessee. Myrtle provides inpatient services for detox and residential treatment and outpatient services for MAT and OBOT Programs.

FOXO Labs, Inc. is a biotechnology company dedicated to improving human health and life span through the development of cutting-edge technology and product solutions for various industries.

For more information about FOXO, visit .

Forward-Looking Statements

This press release contains forward-looking statements. These statements are made under the “safe harbor� provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about the FOXO’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, and a number of factors could cause actual results to differ materially from those contained in any forward-looking statement. These factors include, but are not limited to the risk of changes in the competitive and highly regulated industries in which FOXO operates; variations in operating performance across competitors or changes in laws and regulations affecting FOXO’s business; the ability to implement FOXO’s business plans, forecasts, and other expectations; the ability to obtain financing; the risk that FOXO has a history of losses and may not achieve or maintain profitability in the future; the enforceability of FOXO’s intellectual property, including its patents and the potential infringement on the intellectual property rights of others; and the risk of downturns and a changing regulatory landscape in the highly competitive industries in which FOXO operates. The foregoing list of factors is not exhaustive. Readers should carefully consider the foregoing factors and the other risks and uncertainties discussed in FOXO’s most recent reports on Forms 10-K and 10-Q, particularly the “Risk Factors� sections of those reports, and in other documents FOXO has filed, or will file, with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and FOXO assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.

Contact:

Sebastien Sainsbury

(561) 485-0151


FAQ

What did FOXO Technologies announce about Myrtle Recovery Centers' license renewal?

FOXO announced that Myrtle Recovery Centers successfully renewed its operating license for its Oneida, TN location for another year, following an inspection by the Tennessee Department of Mental Health and Substance Abuse Services.

What is the current operational status of Myrtle Recovery Centers' Tennessee facility?

The facility is operating at full capacity and maintaining a waiting list for future admissions.

What are FOXO Technologies' expansion plans for Myrtle Recovery Centers?

FOXO is actively considering opening a second location and exploring potential acquisitions in the behavioral health sector.

Who is leading Myrtle Recovery Centers and FOXO Technologies?

Robert Merritt serves as CEO of Myrtle Recovery Centers, while Seamus Lagan is the Chief Executive Officer of parent company FOXO Technologies.

What services does Myrtle Recovery Centers provide in Tennessee?

Myrtle Recovery Centers operates an alcohol and drug residential treatment facility in Oneida, Tennessee.
FOXO TECHNOLOGIES

NYSE:FOXO

FOXO Rankings

FOXO Latest News

FOXO Latest SEC Filings

FOXO Stock Data

4.77M
5.24M
9.9%
2.69%
8%
Health Information Services
Services-commercial Physical & Biological Research
United States
WEST PALM BEACH